A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34bright and AC133dim/-CD34+ human cord blood cells

被引:41
|
作者
Goussetis, E [1 ]
Theodosaki, M
Paterakis, G
Peristeri, J
Petropoulos, D
Kitra, V
Papassarandis, C
Graphakos, S
机构
[1] St Sophia Childrens Hosp, Bone Marrow Transplantat Unit, Athens 11527, Greece
[2] G Genimmatas Gen Dist Hosp, Dept Immunol, Athens, Greece
[3] G Genimmatas Gen Dist Hosp, Natl Histocompatibil Ctr, Athens, Greece
来源
关键词
D O I
10.1089/152581600750062255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 5-transmembrane receptor AC133 is expressed on a subpopulation of human hematopoietic cells that includes the CD34(bright) cells. We evaluated the developmental potential of AC133(+)CD34(bright) and AC133(dim-)CD34(+) cells isolated from 5 cord blood (CB) samples by studying the in vitro proliferative and differentiative potential of each population in both progenitor and mature cell expansion cultures. Seven-day culture of AC133(+)CD34(bright) cells with a cytokine combination favoring primitive progenitor cells causes a significant increase in CD34(+), CFU-C and noncycling stent/progenitor cells HPP-Q (High Proliferative Potential-Quiescent), whereas culture of AC133(dim/-)CD34(+) cells shows a limited increase in committed progenitor cells only. HPP-Q cells were not found in freshly isolated AC133(dim/-)CD34(+) nor in expanded CD34(+) cells derived from AC133(dim/-)CD34(+) cells. No statistically significant difference was observed between the 1-week expanded AC133(+) and the initial AC133(+)CD34(bright) cells regarding their clonogenic efficiency (CE), while expanded CD34(+) cells derived from AC133(dim/-)CD34(+) cells exhibited a decreased CE. Subexpansion of the reselected AC133+ derived from AC133(+)CD34(bright) cells reveals a further increase of stent/progenitor cells and the 14-day expanded AC133+ cells reveal an unchanged CE. Subexpansion of reselected 7-day CD34(+) cells derived from AC133(dim/-)CD34(+) cells was not possible. Culture of AC133(+)CD34(bright) cells in cytokines that favor megakaryopoiesis or erythropoiesis resulted in a significant expansion of CD41(+) and CD71(+) cells, respectively; AC133(dim/-)CD34(+), in comparison, showed a limited potential to megakaryocytic differentiation and a decreased production of erythroid cells. Our data indicate that early high proliferating stem/progenitor cells and early committed progenitors are present in AC133(+)CD34(bright) cells, but not in AC133(dim/-)CD34(+) cells; the latter represent late committed progenitors with limited proliferative potential.
引用
收藏
页码:827 / 840
页数:14
相关论文
共 50 条
  • [31] Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells
    Hemmoranta, Heidi
    Hautaniemi, Sampsa
    Niemi, Jari
    Nicorici, Daniel
    Laine, Jarmo
    Yli-Harja, Olli
    Partanen, Jukka
    Jaatinen, Taina
    STEM CELLS AND DEVELOPMENT, 2006, 15 (06) : 839 - 851
  • [32] Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia
    Monreal, MB
    Pardo, ML
    Pavlovsky, MA
    Fernandez, I
    Corrado, CS
    Giere, I
    Sapia, S
    Pavlovsky, S
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2006, 70B (02) : 63 - 70
  • [33] Cytokine mediated expansion of human umbilical cord blood CD34+ cells: comparison of the use of partially purified and pure CD34+ target cells
    Case, J
    Rice, A
    Vowels, M
    HEMATOLOGY AND CELL THERAPY, 1997, 39 (04) : 193 - 197
  • [34] Ultrastructural characterisation of CD34+ cord blood cells.
    Caneva, L
    Fumiatti, R
    Soligo, D
    Lecchi, L
    Sirchia, G
    Deliliers, GL
    BONE MARROW TRANSPLANTATION, 1999, 23 : S11 - S11
  • [35] Occurrence of apoptosis in cord blood CD34+ cells.
    Greco, NJ
    Lee, WR
    Kurtz, J
    Seetharaman, S
    Moroff, G
    BLOOD, 2003, 102 (11) : 172B - 172B
  • [36] Rosuvastatin Increases the Relative Number of CD34+/KDR+ but not CD34+/CD133+Endothelial Progenitor Cells in Elderly Hypercholesterolemic Patients.
    Iturry-Yamamoto, German
    Machado, Denise
    Bruscato, Neide
    Vieira, Jose
    Moriguchi, Emilio
    CIRCULATION, 2010, 122 (02) : E27 - E27
  • [37] Differentiation of CD34+ cord blood cells in glycosaminoglycan microcapsules
    Buruzula, GK
    Matthew, HWT
    Eliason, JF
    PROCEEDINGS OF THE IEEE 30TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 2004, : 114 - 115
  • [38] A UNIQUE POPULATION OF CD34+ CELLS IN CORD-BLOOD
    NIMGAONKAR, M
    ROSCOE, R
    PERSICHETTI, J
    RYBKA, W
    WINKELSTEIN, A
    BALL, ED
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 756 - 756
  • [39] Phenotypic and functional characterization of mobilized peripheral blood AC133+CD34+ hematopoietic stem cells.
    Kuci, S
    Schumm, M
    Schlegel, PG
    Seitz, G
    Grau, R
    Niethammer, D
    Handgretinger, R
    BLOOD, 1999, 94 (10) : 559A - 559A
  • [40] Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+ CD133+ Stem Cells in Patients With Type 2 Diabetes
    Fadini, Gian Paolo
    Rigato, Mauro
    Cappellari, Roberta
    Bonora, Benedetta Maria
    Avogaro, Angelo
    DIABETES CARE, 2017, 40 (01) : 125 - 131